PeptideDB

BDM91270 2892824-11-0

BDM91270 2892824-11-0

CAS No.: 2892824-11-0

BDM91270 (compound 29) is an E. coli AcrAB-TolC efflux pump inhibitor, and its EC90 value for inhibiting wild-type E. co
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

BDM91270 (compound 29) is an E. coli AcrAB-TolC efflux pump inhibitor, and its EC90 value for inhibiting wild-type E. coli AcrB is 0.6 μM. BDM91270 may be utilized to study drug resistance in E. coli.

Physicochemical Properties


CAS # 2892824-11-0
Appearance Off-white to light yellow solid powder
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets EC90: 0.6 μM (AcrB)[1].
References [1]. Compagne N, et al. Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump. Eur J Med Chem. 2023 Jul 7;259:115630.

Solubility Data


Solubility (In Vitro) H2O : 50 mg/mL (119.12 mM)
DMSO : 25 mg/mL (59.56 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (5.96 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (5.96 mM) (saturation unknown) in 10% DMSO + 90% PBS (add these co-solvents sequentially from left to right, and one by one), clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)